Keros Therapeutics Inc

Keros Therapeutics Inc

KROS

Market Cap$546.28M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Keros Therapeutics IncKeros Therapeutics Inc129.5-1%2.8-
$13.86

Current Fair Value

0.3% downside

Overvalued by 0.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$546.28 Million
Enterprise Value$-142,499,870.00
Dividend Yield$0 (0%)
Earnings per Share$-5
Beta1.3
Outstanding Shares40,559,355

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio129.52
PEG-29.15
Price to Sales2.78
Price to Book Ratio0.82
Enterprise Value to Revenue-0.66
Enterprise Value to EBIT35.45
Enterprise Value to Net Income-34
Total Debt to Enterprise-0.22
Debt to Equity0.04

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Keros Therapeutics Inc